Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8671628 | Journal of Vascular Surgery | 2018 | 7 Pages |
Abstract
The preliminary results of this real-world multicenter study showed that EVAS with Nellix for the management of AAAs appears feasible. This device platform is associated with acceptable procedure-related mortality and low overall complication and reintervention rates. Definitive conclusions on the value of this novel device await long-term follow-up data.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Bruno MD, Ombretta MD, Michelangelo MD, Roberto MD, Fabio MD,